Rutgers Cancer Institute of New Jersey Chair of Radiation Oncology and Associate Vice Chancellor of Cancer Programs Receives Prestigious National Award
Bruce G. Haffty, MD, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been selected as the 2020 Gold Medal Award winner by the American Society for Radiation Oncology (ASTRO),...
27-May-2020 12:25 PM EDT Add to Favorites
For this 2020 World No Tobacco Day, experts from the Rutgers Tobacco Dependence Program discuss New Jersey quit centers and how quitting tobacco can benefit one during cancer treatment.
19-May-2020 10:05 AM EDT Add to Favorites
Researchers from Rutgers Cancer Institute of New Jersey along with collaborators from Princeton University identify a new drug that has therapeutic effect against the aggressive hematological disease T-cell acute lymphoblastic leukemia.
12-May-2020 10:50 AM EDT Add to Favorites
Superior Progression-Free Survival Associated with Continuous Targeted Therapy Combination for BRAF-mutated Melanoma
Results from a randomized phase 2 clinical trial examining the targeted therapy drugs dabrafenib and tremetinib in both continuous and intermittent treatment of patients with BRAF-mutated melanoma show continuous dosing yields superior progression...
27-Apr-2020 9:00 AM EDT Add to Favorites
While most public, hospital and academic libraries are closed to visitors due to the COVID-19 pandemic, there is a wealth of information available online, especially for cancer patients seeking disease specific information. Rutgers Cancer Institute...
15-Apr-2020 8:50 AM EDT Add to Favorites
Rutgers Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center, is offering a clinical trial as a potential treatment for patients diagnosed with the coronavirus (COVID-19). The trial, which is not limited...
3-Apr-2020 1:35 PM EDT Add to Favorites
Rutgers Cancer Institute of New Jersey Research Shows Autophagy Impacts Stress Response Pathways Promoting Survival in Laboratory Models
Research from investigators at Rutgers Cancer Institute of New Jersey shows that a cellular process known as autophagy promotes survival in mouse models by suppressing oxidative stress and a tumor suppressor known as p53.
18-Mar-2020 4:00 PM EDT Add to Favorites
Addition of Immunotherapy to Standard Treatment for Advanced Stage Non-Small Cell Lung Cancer is Safe and Tolerable as First-Line Therapy
Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for...
18-Feb-2020 4:05 PM EST Add to Favorites
See All News
One of the hallmarks of a National Cancer Institute-designated Comprehensive Cancer Center is the unique oncology expertise exhibited by its clinical team, including board certified oncology pharmacists. A Rutgers Cancer Institute of New Jersey...
18-Oct-2019 8:00 AM EDT
As more women live with breast cancer, minimization of significant deformity in the breast after breast preservation is increasingly gaining attention. A Rutgers Cancer Institute of New Jersey surgical oncologist shares some insight.
25-Sep-2019 2:05 PM EDT
An estimated 61,780 new cases of leukemia will be diagnosed in the United States this year. Although leukemias are thought to occur in childhood, they can actually present at any age in both children and adults.
30-Aug-2019 8:05 AM EDT
Colorectal cancer is the third leading cancer in both new cases and cancer deaths in the United States. While colorectal cancer incidence declined 3.7 percent annually from 2006 to 2015 for those 55 and older, rates have increased 1.8 percent...
18-Mar-2019 3:05 PM EDT
In the U.S., lung cancer remains the leading cause of cancer death among both men and women. The primary reason for high death rates for lung cancer is the fact that this disease is typically detected in very late stages. A Rutgers University expert...
30-Oct-2018 5:05 PM EDT
Sickle cell disease is a common inherited blood disorder, affecting an estimated 100,000 Americans of different racial and ethnic groups. A Rutgers Cancer Institute of New Jersey expert shares more about the importance of early diagnosis and...
24-Sep-2018 8:00 AM EDT
While thyroid cancers are common, they may not be as widely understood as other common cancers such as breast or prostate. A Rutgers Cancer Institute of New Jersey expert shares more about the
butterfly-shaped gland in the lower neck and how...
18-Sep-2018 8:00 AM EDT
During this Gynecologic Cancers Awareness Month, a Rutgers Cancer Institute of New Jersey expert shares info on symptoms and treatment of ovarian cancer.
14-Sep-2018 12:00 PM EDT